Researchers combined engineered viral vectors with the brain’s glymphatic transport system to deliver genes to glial cells.

The industry tends to treat manufacturing as a back-end operational concern. For advanced therapies, it isn't. In cell and ...

By registering the LongCat-2.0 repository under the open-source MIT License, Meituan positions the architecture with maximum ...

Refael Angel, Co-Founder and CTO of Akeyless, is a cybersecurity and software engineering leader with deep experience in ...

Sixty percent of surveyed South Africa-based chief information security officers reveal third-party risk remains a major ...

A new study describes a gene therapy strategy that uses the brain's own glymphatic transport system to distribute engineered viral vectors throughout the brain.

As genome editing therapies move through clinical trials to regulatory approval, scientists continue the quest for the holy ...

Intersignal, an independent artificial intelligence research and systems engineering initiative, today announced the release of Braid Pathfinder v0.5, a hardened developer preview of its local AI ...

As India is moving steadily toward its ambition of becoming a $5 trillion economy, much of that growth will continue to be driven by large industries such as:- Mining & Resource Extraction- ...

Spot Biosystems, a gene therapy company pioneering a novel non-viral extracellular vesicle (EV) delivery platform for genetic ...

Anyone who has watched a trader blow up a desk will recognize the pattern: mounting losses, narrowing options, the slow slide from discipline into desperation, and then the catastrophic shortcut that ...